Orchid Pharma P/E Ratio
Orchid Pharma (ORCHPHARMA) P/E ratio is not applicable — EPS (TTM) ₹19.65, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹19.65
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -1.13 | -6 | Loss |
| Mar 2025 | 4.40 | 22 | Profit |
| Jun 2025 | 2.94 | 15 | Profit |
| Dec 2025 | -2.49 | -13 | Loss |
| Sept 2024 | 5.37 | 27 | Profit |
| Mar 2024 | 6.81 | 33 | Profit |
| Jun 2024 | 5.79 | 29 | Profit |
| Dec 2024 | 4.10 | 21 | Profit |
Healthcare Peers with Valid P/E Ratios — ORCHPHARMA Comparison
Healthcare sector average P/E 48.22, median 26.94 — ORCHPHARMA excluded (negative EPS).
Sector Average PE
48.22
Sector Median PE
26.94
Lowest PE
1.17
Profitable Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 5.67 | ₹64 | Low |
| Medicamen Organics | MEDIORG | 6.4 | ₹27 | Low |
| Zenith Drugs | ZENITHDRUG | 6.83 | ₹69 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Accretion Pharmaceuticals | ACCPL | 10.92 | ₹78 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Orchid Pharma share price today.
- Analyse ORCHPHARMA shareholder distribution to track promoter, FII and institutional holdings.
- View ORCHPHARMA 52-week high low for the annual high/low range and current price position.